PANoptosis in intestinal epithelium: its significance in inflammatory bowel disease and a potential novel therapeutic target for natural products

被引:0
|
作者
Zhao, Chuanxiang [1 ]
Lin, Shan [1 ]
机构
[1] Jiangsu Coll Nursing, Inst Med Genet & Reprod Immun, Sch Med Sci & Lab Med, Huaian, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2025年 / 15卷
关键词
inflammatory bowel disease; intestinal epithelium; cell death; PANoptosis; natural products; CELL-DEATH; GASDERMIN D; CYTOCHROME-C; ACTIVATION; APOPTOSIS; CASPASE-8; ALPHA; NECROPTOSIS; PYROPTOSIS; MLKL;
D O I
10.3389/fimmu.2024.1507065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The intestinal epithelium, beyond its role in absorption and digestion, serves as a critical protective mechanical barrier that delineates the luminal contents and the gut microbiota from the lamina propria within resident mucosal immune cells to maintain intestinal homeostasis. The barrier is manifested as a contiguous monolayer of specialized intestinal epithelial cells (IEC), interconnected through tight junctions (TJs). The integrity of this epithelial barrier is of paramount. Consequently, excessive IEC death advances intestinal permeability and as a consequence thereof the translocation of bacteria into the lamina propria, subsequently triggering an inflammatory response, which underpins the clinical disease trajectory of inflammatory bowel disease (IBD). A burgeoning body of evidence illustrates a landscape where IEC undergoes several the model of programmed cell death (PCD) in the pathophysiology and pathogenesis of IBD. Apoptosis, necroptosis, and pyroptosis represent the principal modalities of PCD with intricate specific pathways and molecules. Ample evidence has revealed substantial mechanistic convergence and intricate crosstalk among these three aforementioned forms of cell death, expanding the conceptualization of PANoptosis orchestrated by the PNAoptosome complex. This review provides a concise overview of the molecular mechanisms of apoptosis, necroptosis, and pyroptosis. Furthermore, based on the crosstalk between three cell deaths in IEC, this review details the current knowledge regarding PANoptosis in IEC and its regulation by natural products. Our objective is to broaden the comprehension of innovative molecular mechanisms underlying the pathogenesis of IBD and to furnish a foundation for developing more natural drugs in the treatment of IBD, benefiting both clinical practitioners and research workers.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Inflammatory bowel disease: Potential therapeutic strategies
    Nielsen, OH
    Vainer, B
    Bregenholt, S
    Claesson, MH
    Bishop, PD
    Kirman, I
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1997, 3 (04) : 267 - 281
  • [32] Microecology as a target for therapeutic intervention in inflammatory bowel disease
    Guarner, F
    IDRUGS, 2003, 6 (09) : 868 - 873
  • [33] Lymphangiogenesis in Inflammatory Bowel Disease; A New Therapeutic Target?
    Koutroubakis, Ioannis E.
    Binion, David G.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7
  • [34] Abdominal pain as a therapeutic target in inflammatory bowel disease
    Hodgson, HJF
    TARGETS OF TREATMENT IN CHRONIC INFLAMMATORY BOWEL DISEASES, 2003, 131 : 188 - 192
  • [35] Novel therapeutic targets for inflammatory bowel disease
    Argollo, Marjorie
    Fiorino, Gionata
    Hindryckx, Pieter
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    JOURNAL OF AUTOIMMUNITY, 2017, 85 : 103 - 116
  • [36] Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential
    Xu, Qiuyun
    Sun, Weichen
    Zhang, Jie
    Mei, Youmin
    Bao, Jingyin
    Hou, Shengping
    Zhou, Xiaorong
    Mao, Liming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] The use of natural products in the treatment of inflammatory bowel disease
    Triantafillidis, J. K.
    ANNALS OF GASTROENTEROLOGY, 2008, 21 (01): : 14 - 16
  • [38] Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease
    Akira Andoh
    Yoshihide Fujiyama
    World Journal of Gastroenterology, 2006, (28) : 4452 - 4460
  • [39] Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease
    Andoh, Akira
    Fujiyama, Yoshihide
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (28) : 4452 - 4460
  • [40] Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?
    Timna Naftali
    Digestive Diseases and Sciences, 2019, 64 : 2696 - 2698